HPV E6/E7 mRNA Typing Detection

In vitro qualitative detection kit for 15 high-risk HPV E6/E7 mRNA subtypes in cervical exfoliated cell samples. Detects HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68 for cervical cancer and precancerous lesion risk assessment. NMPA Class III medical device registered.

HPV E7 protein detection system for cervical cytology screening. Identifies HPV E7 biomarkers in cervical samples for disease risk assessment. Supports early detection of HPV-related cervical pathology.

A diagnostic kit for qualitative detection of 15 high-risk HPV E6/E7 mRNA types (16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68) in cervical exfoliated cell samples. The kit detects HPV at the viral gene transcription level, directly reflecting the expression of HR-HPV E6/E7 oncogenic genes, and is closely associated with viral integration and cellular malignant transformation. It can serve as a risk assessment tool for cervical cancer and precancerous lesions, providing accurate information for cervical cancer screening and disease prediction.

HPV E7 protein detection kit using immunocytochemical methodology for cervical cytology screening. This in vitro diagnostic test identifies HPV E7 protein expression in cervical samples to support the detection of cervical lesions and dysplasia. The kit enables standardized pathology assessment with compatible automated analysis integration for improved diagnostic accuracy.

A fluorescent PCR melting curve method-based detection kit for genotyping Human Papillomavirus through E6/E7 mRNA analysis. This kit enables molecular diagnostics of HPV infections at the mRNA level.

Molecular diagnostic assay for detecting and genotyping high-risk human papillomavirus strains. Supports cervical cancer screening and risk stratification.

Molecular assay for identifying 14 WHO-defined high-risk HPV types and 4 additional clinically relevant HPV types associated with cervical cancer. Enables comprehensive cervical cancer risk stratification.

PCR-based human papillomavirus detection assay capable of identifying 23 HPV genotypes including 18 high-risk and 5 low-risk variants for cervical cancer screening and auxiliary diagnosis.

Single-tube HPV detection assay that identifies 14 high-risk HPV genotypes, satisfying cervical cytology screening requirements with streamlined testing methodology.

A comprehensive system for HPV virus detection in cervical screening programs. The collection and preservation methodology ensures accurate identification of high-risk HPV strains for cancer prevention.

A fully enclosed diagnostic kit with preloaded reagents for 6-plex detection of HPV types (HPV16, HPV18, and others) using cervical exfoliated cells and genital secretion samples. The kit employs magnetic beads extraction, purification, and qPCR method with results available within 2 hours and internal control monitoring throughout the process. It requires no freezer storage or transportation.

A fluorescence PCR-based qualitative detection kit for identifying 15 types of human papillomavirus DNA from cervical or urine samples. Includes CE certification and enables specific genotype differentiation.